The quick read: Yes, if the actual loan permits collateral cash to satisfy a defined test without applying it to principal. That contractual cure can change the test denominator while the mortgage balance remains outstanding. Compare deposit, repayment and release treatment separately. A ratio improved by cash collateral does not establish higher property income, lower interest charges or unrestricted access to the deposited money.
What distinguishes a collateral cure from an actual principal payment?
A collateral cure differs from a principal payment when the loan holds money as additional security and credits it only in a defined covenant calculation rather than applying it to reduce the outstanding debt. Trace the contractual treatment and ledger separately. Calling both transactions a cure can hide different interest, liquidity and payoff consequences for the investor.
Read the signed loan and account provisions before selecting either approach. Identify what the lender is required or permitted to do with the money and how the defined test reflects it. A deposit notice is not evidence of principal already credited; an actual repayment is not simply a refundable balance held for later release.
An actual 2026 SEC-filed property loan, section 12.6.1, separates principal prepayment from a cash-or-letter collateral deposit credited in its debt-yield calculation. This negotiated mechanism does not establish that every bridge loan permits the same options or that its terms apply to another borrower. SEC-filed cure provision.
For the financing comparison, use the actual clause rather than infer treatment from a payment label. If the loan offers only one route or requires separate approval, record that limitation. The borrower should not create a collateral alternative in its spreadsheet that the signed agreement does not provide.
Which debt-yield amount does the covenant actually use?
The covenant's debt-yield amount depends on its defined income and denominator, so the investor should reproduce those inputs before concluding that a cash deposit satisfies a trigger or changes the actual mortgage balance. Keep test debt separate from ledger principal. A contract can adjust a calculation for collateral without converting that collateral into a payment of the underlying loan.
The 2026 agreement's Debt Yield definition and section 12.6 describe specified cash or instrument deductions for its calculation. Those provisions must be read with the relevant trigger and account terms. Do not replace them with a generic NOI-divided-by-loan formula and then assume the result governs every covenant in the package.
Identify the income period, permitted adjustments, principal date and qualifying collateral. A deposit might matter for one test without changing another condition for extensions, distributions or refinancing. Ask the lender to confirm the reproduced calculation and the evidence required for the actual cure.
Keep the property's operating case visible. If accepted income has fallen, collateral treatment does not by itself restore rent collections or reduce operating bills. A reported passing contractual test and an improved property business plan can be different outcomes.
What does a hypothetical collateral-cure calculation show?
A hypothetical collateral-cure calculation shows how a permitted denominator adjustment can produce the assumed target ratio without changing property income or actual principal, provided the relevant contract expressly allows that treatment. Label the formula and inputs as assumptions. The illustration below is not a current bridge threshold, loan quote or determination of any real property's accepted NOI.
Assume annual accepted income is $720,000, outstanding principal is $10,000,000 and the fictional contract's target is 8% debt yield. The unadjusted ratio is 7.2%. To reach 8% with unchanged income, the test denominator must be $9,000,000: $720,000 divided by 0.08.
Assume the fictional contract allows a $1,000,000 cash collateral deposit to be deducted solely for that test. The adjusted ratio becomes 8%, but ledger principal remains $10,000,000 until a real application occurs. If the borrower instead makes an approved $1,000,000 principal payment, actual debt becomes $9,000,000 under that separate assumed route.
Table 1: Hypothetical collateral cure versus actual repayment
| Measure | Cash collateral route | Principal-payment route |
|---|---|---|
| Measure Property income used | Cash collateral route $720,000 | Principal-payment route $720,000 |
| Measure Owner cash supplied | Cash collateral route $1,000,000 | Principal-payment route $1,000,000 |
| Measure Actual principal after assumed transaction | Cash collateral route $10,000,000 | Principal-payment route $9,000,000 |
| Measure Denominator used for the assumed test | Cash collateral route $9,000,000 | Principal-payment route $9,000,000 |
| Measure Calculated test ratio | Cash collateral route 8% | Principal-payment route 8% |
| Measure Money held for potential conditional release | Cash collateral route $1,000,000 assumed | Principal-payment route No deposit assumed |
The same calculated ratio therefore conceals different debt and cash treatment. Neither route establishes that interest, fees, other covenants or the scheduled payment change automatically. Obtain the actual agreement and ledger response before accepting the economic comparison.
How could the two routes affect interest without changing income?
The two routes can affect interest differently if one reduces the balance on which interest is charged while the other leaves actual principal outstanding, so the borrower should compare the note's calculation with the cure-account treatment. State every assumption. A covenant denominator is not necessarily the balance used to calculate the next interest payment.
For a separate fictional simple-interest example, assume ordinary annual interest is 6% of actual outstanding principal, with no floor, minimum interest, other charge or rate change. Interest on $10,000,000 is $600,000 annually. Interest on $9,000,000 is $540,000, a $60,000 annual difference under those assumptions.
That comparison assumes the principal payment is permitted and fully credited for the interest calculation. The actual loan can include prepayment conditions, costs or other features requiring review. Do not describe a collateral deposit as producing the same saving merely because its covenant test uses $9,000,000.
Likewise, any earnings on deposited collateral need the actual account terms and treatment. The illustration assumes no such earnings and does not predict a return. Keep a possible account receipt separate from the mortgage's owed interest and the owner's unrestricted cash budget.
When can deposited cure cash become available again?
Deposited cure cash becomes available again only through the actual account's release provisions and confirmed process, so the borrower should not budget a refund simply because the collateral-adjusted test now passes. Identify whether release requires performance without adjustment, an observation period or absence of other triggers. A contractual cure and release of its supporting cash can occur at different times.
The 2026 specimen's section 12.6.2 requires its specified performance over two consecutive fiscal quarters without deducting cure collateral, no other continuing Trigger Period and a written request for release. These are transaction-specific conditions. They do not guarantee that a deposit made today returns on a calendar date chosen by the investor.
In the fictional example, unchanged $720,000 income divided by actual $10,000,000 principal remains 7.2% without the deposit adjustment. It therefore does not meet the assumed 8% unadjusted test. If accepted income later becomes $830,000, the unadjusted ratio is 8.3%; any required periods, evidence and other conditions still need confirmation.
Do not count the same $1,000,000 as both cure collateral and owner liquidity for repairs. Until release is established and the funds are usable, it remains a restricted source in the cash plan rather than money available for another immediate commitment.
How should collected cash applied to debt differ from money merely held?
Collected cash applied to debt should differ from money merely held because application can change the balance while retention provides security or supports a later permitted use. Reconcile account deposits, instructions and actual ledger credits. A funds account can participate in a cure without every deposit becoming immediate principal repayment or every reported balance becoming a refundable owner receipt.
A separate 2013 SEC-filed property loan, section 4.13, permits application of its collected funds to a required remargin payment at the borrower's request, with any remaining deficiency supplied elsewhere. That is an actual-payment route under a different historical agreement, not the same collateral-only calculation described in the 2026 specimen. SEC-filed account-application clause.
The comparison is a document question: is the money still held, authorized for application or actually credited? Request a dated statement that answers it. Do not reduce the payoff twice by subtracting both a reserve balance and a principal payment already funded from that reserve.
If the lender later applies a deposit, update the balance and restricted account together. Keep expenses, interest and other obligations identifiable. A total cash movement does not establish how much principal changed without its actual allocation.
How should the investor compare cure cash with the property's other uses?
The investor should compare cure cash with the property's other uses on a dated sources-and-uses schedule because either a collateral deposit or principal payment can consume money needed for operations, repairs or refinance. Identify accessible resources and pending releases. A passing ratio does not ensure the investor can fund a separate invoice or planned ownership distribution on time.
Assume separately the owner has $1,400,000 unrestricted and must supply the fictional $1,000,000 cure. It retains $400,000. If another $600,000 of property costs is due before any new usable receipt, the gap is $200,000. A potential future return of the cure deposit should not fill that earlier gap without confirmed timing.
The OCC 2023-23 bulletin encourages covered banks to work prudently with creditworthy borrowers and describes the agencies' CRE accommodations and workouts policy. It does not entitle this borrower to a waiver, collateral cure or release. Use the actual accepted agreement for any revised solution. OCC bulletin.
Use the debt-yield glossary for the ratio and the bridge financing page for the interim request. Keep contractual compliance, property income and owner liquidity distinct so the financing comparison describes what the proposed cure changes and what it leaves unresolved.
How should a cure-versus-repayment choice be presented for placement?
Present a cure-versus-repayment choice for borrower placement with the actual clause, accepted test inputs and confirmed account or principal treatment so the financing discussion compares the same facts across proposed routes. Include interest and release assumptions separately. Show other cash obligations and pending approvals rather than treat a collateral-adjusted ratio as new income, paid principal or available owner money.
Every credit decision is made by the lender; YieldStack arranges the introductions and negotiates on the borrower's side, and no loan, rate, or closing is guaranteed.
Submit the bridge request and cure-account reconciliation.
The bottom line
A permitted collateral cure can improve a contractual test without paying principal or increasing income. Trace the account and ledger, compare actual interest and release conditions, and fund competing property needs. The same ratio can describe different economics. Use confirmed contract treatment and accessible cash before choosing deposit, repayment or a separately approved modification.